Access to Substance Use Disorder Services. a. In collaboration with the County, Contractor will work to ensure that individuals to whom the Contractor provides SUD services meet access criteria and medical necessity requirements, as per DHCS guidance specified in BHIN 24-001. Specifically, the Contractor will ensure that the clinical record for each client includes information as a whole indicating that client’s presentation and needs are aligned with the criteria applicable to their age at the time of service provision as specified below. b. Contractor shall have written admission criteria for determining the client’s eligibility and suitability for treatment and services. All clients admitted shall meet the admission criteria and this shall be documented in the client’s record. c. Programs shall ensure that their policies, procedures, practices, and rules and regulations do not discriminate against the above special populations. Whenever the needs of the client cannot be reasonably accommodated, efforts shall be made to make referral(s) to appropriate programs. d. Contractor should recognize and educate staff and collaborative partners that Parole and Probation status is not a barrier to SUD services. e. Contractor will ensure that the clinical record for each client includes information as a whole indicating that client’s presentation and needs are aligned with the criteria applicable to their age at the time-of-service provision as outlined in this Agreement. f. In collaboration with the County, Contractor will work to ensure delivery of the following service components: Intensive Outpatient Treatment includes the following service components: • Assessment • Individual Counseling • Group Counseling • Patient Education • Medication Services • MAT for OUD • SUD Crisis Intervention Services Outpatient Services include the following components: • Assessment • Individual Counseling • Group Counseling • Patient Education • Medication Services MAT for OUD • Crisis Intervention Services Medicated Assisted Treatment includes the following service components: • Assessment • Care Coordination • Counseling (individual and Group) • Family Therapy • Medication Services • Patient Education • Recovery Services • SUD Crisis Intervention Services • Withdrawal Management Services • Prescribing and monitoring MAT for AUD and Other Non-Opioid Substance Use Disorders, which consists of prescribing, administering, dispensing, ordering, monitoring, and/or managing the medications used for MAT services for AUD and Other Non-Opioid Substance Use Disorders g. In collaboration with the County, Contractor will implement a MAT policy in compliance with HSC 11832.9(c), 11834.28(c) and BHIN 23-054. The MAT policy shall include: 1. Procedures on how a client receives information about the benefits and risks of MAT (HSC Section 11832.9(c)(1); HSC Section 11834.28(c)(1)) . Information must be specific to each type of medication approved for treating a client’s SUD(s). This includes: a. When a client and/or family member will receive information (e.g., at intake, during treatment, at discharge); b. Whether the facility will present follow-up information to a client about MAT, if the client initially refuses MAT; c. Who will present MAT information to a client (e.g., LPHA), Alcohol and Other Drug (AOD) counselor, other facility staff); d. What information will be provided (e.g., pamphlets, websites, contact information for local providers) that clearly explain the benefits of MAT and the risks of not accepting MAT; e. What information will be documented when MAT is provided to a client (e.g., progress notes, informed consent, a client’s refusal of MAT, history of use of MAT.). 2. Procedures regarding availability of MAT at the facility, if applicable, or the referral process for MAT (HSC Section 11832.9(c)(2); HSC Section 11834.28(c)(2)). This includes: a. If MAT is available at the facility: 1. Eligibility requirements; 2. All FDA-approved medications available; 3. Frequency of follow-up appointments for MAT treatment; 4. A referral process as specified in paragraph b for all FDA- approved medications that are not available at the facility. b. If MAT is not available at the facility: 1. Referral locations for each type of medication approved for treating their SUD(s), including name, address, phone number, website, and distance from the facility; 2. Minimum number of MAT locations that the facility will refer to; 3. Procedures for a client who have established care for MAT prior to admission; 4. Client transportation to/from MAT locations. 3. A description of the evidence-based assessment the facility will use for determining a client’s MAT needs. (HSC Section 11832.9(c)(3); HSC Section 11834.28(c)(3)). This includes: a. Procedures for selecting an evidence-based assessment; b. Description of the evidence-based assessment selected by the facility; c. Process for conducting the assessment, which states: 1. The evidence-based assessment shall be performed by a LPHA or AOD counselor within the first twenty-four (24) hours of admission. 2. If the evidence-based assessment indicates that MAT would be beneficial for the client, within forty-eight (48) hours of the admission: a. The client must be evaluated by an LPHA who can determine if MAT initiation is appropriate and prescribe the medication(s). b. The prescribed MAT medications must be provided to the client in alignment with the program’s approved policies and procedures. 4. Procedures regarding administration, storage, and disposal of MAT, if applicable (HSC Section 11832.9(c)(4); HSC Section 11834.28(c)(4)). This includes: a. A separate medication policy if MAT is administered, stored, or disposed of differently than non-MAT medications, or include MAT in the current medication administration, storage, and disposal policies and procedures (if applicable); b. A separate medication policy for MAT shall address: 1. Medication administration requirements for self-administration and documentation; 2. Storage requirements, including location, accessibility, inventory, handling, and documentation; 3. Medication disposal procedures, including how often, methods of destruction, and documentation. 5. Procedures for training for staff if applicable (HSC Section 11832.9(c)(5); HSC Section 11834.28(c)(5)). This includes: 6. An outline of the training the facility will provide to staff on the facility’s MAT policy. (HSC Section 11832.9(c)(6); HSC Section 11834.28(c)(6)). This includes: a. Frequency of training (upon hire, quarterly, annual, etc.); b. Qualifications to conduct training; c. Staff positions required to receive training; d. Documentation of training in personnel files. 7. A plan that permits a client to use their preferred MAT medication, if the prescriber or MAT provider and the client determine the medication is clinically beneficial. This includes: a. Access to the facility shall not be denied because of a client’s use of prescribed medications for the treatment of SUD; b. Assurance that a client is not required to change their MAT medication in order to receive treatment services; c. Support for a client who wants to continue to receive their preferred MAT medications; d. Confirmation that a client will not be compelled to taper, discontinue, decrease dosage, or abstain from medications provided as part of MAT as a condition of entering or remaining in the facility ; e. Assurance that a client is not denied access to medications as part of MAT for not participating in all services offered by a facility ; f. Assurance that a client is not denied access to medications as part of MAT for substance use or misuse. 8. Procedures for a client to access NTP medications for opioid use disorder (MOUD), including methadone. This includes: a. Information regarding methadone, including the evidence base, effectiveness, associated risks and benefits, and key considerations to support informed consent;
Appears in 1 contract
Sources: Service Agreement
Access to Substance Use Disorder Services. a. In collaboration with the County, Contractor will work to ensure that individuals to whom the Contractor provides SUD services meet access criteria and medical necessity requirements, as per DHCS guidance specified in BHIN 24-001. Specifically, the Contractor will ensure that the clinical record for each client includes information as a whole indicating that client’s presentation and needs are aligned with the criteria applicable to their age at the time of service provision as specified below.
b. Contractor shall have written admission criteria for determining the client’s eligibility and suitability for treatment and services. All clients admitted shall meet the admission criteria and this shall be documented in the client’s record.
c. Programs shall ensure that their policies, procedures, practices, and rules and regulations do not discriminate against the above special populations. Whenever the needs of the client cannot be reasonably accommodated, efforts shall be made to make referral(s) to appropriate programs.
d. Contractor should recognize and educate staff and collaborative partners that Parole and Probation status is not a barrier to SUD services.
e. Contractor will ensure that the clinical record for each client includes information as a whole indicating that client’s presentation and needs are aligned with the criteria applicable to their age at the time-of-service provision as outlined in this Agreement.
f. In collaboration with the County, Contractor will work to ensure delivery of the following service components: Intensive Outpatient Treatment includes the following service components: • Assessment • Individual Counseling • Group Counseling • Patient Education • Medication Services • MAT for OUD • SUD Crisis Intervention Services Outpatient Services include the following components: • Assessment • Individual Counseling • Group Counseling • Patient Education • Medication Services MAT for OUD • Crisis Intervention Services Medicated Assisted Treatment includes include the following service components: • Assessment • Care Coordination • Counseling (individual and Group) • Family Therapy • Medication Services • Patient Education • Recovery Services • SUD Crisis Intervention Services • Withdrawal Management Services • Prescribing and monitoring MAT for AUD and Other Non-Opioid Substance Use Disorders, which consists of prescribing, administering, dispensing, ordering, monitoring, and/or managing the medications used for MAT services for AUD and Other Non-Opioid Substance Use Disorders
g. In collaboration with the County, Contractor will implement a MAT policy in compliance with HSC 11832.9(c), 11834.28(c) and BHIN 23-054. The MAT policy shall include:
1. Procedures on how a client receives information about the benefits and risks of MAT (HSC Section 11832.9(c)(1); HSC Section 11834.28(c)(1)) . Information must be specific to each type of medication approved for treating a client’s SUD(s). This includes:
a. When a client and/or family member will receive information (e.g., at intake, during treatment, at discharge);
b. Whether the facility will present follow-up information to a client about MAT, if the client initially refuses MAT;
c. Who will present MAT information to a client (e.g., LPHA), Alcohol and Other Drug (AOD) counselor, other facility staff);
d. What information will be provided (e.g., pamphlets, websites, contact information for local providers) that clearly explain the benefits of MAT and the risks of not accepting MAT;
e. What information will be documented when MAT is provided to a client (e.g., progress notes, informed consent, a client’s refusal of MAT, history of use of MAT.).
2. Procedures regarding availability of MAT at the facility, if applicable, or the referral process for MAT (HSC Section 11832.9(c)(2); HSC Section 11834.28(c)(2)). This includes:
a. If MAT is available at the facility:
1. Eligibility requirements;
2. All FDA-approved medications available;
3. Frequency of follow-up appointments for MAT treatment;
4. A referral process as specified in paragraph b for all FDA- approved medications that are not available at the facility.
b. If MAT is not available at the facility:
1. Referral locations for each type of medication approved for treating their SUD(s), including name, address, phone number, website, and distance from the facility;
2. Minimum number of MAT locations that the facility will refer to;
3. Procedures for a client who have established care for MAT prior to admission;
4. Client transportation to/from MAT locations.
3. A description of the evidence-based assessment the facility will use for determining a client’s MAT needs. (HSC Section 11832.9(c)(3); HSC Section 11834.28(c)(3)). This includes:
a. Procedures for selecting an evidence-based assessment;
b. Description of the evidence-based assessment selected by the facility;
c. Process for conducting the assessment, which states:
1. The evidence-based assessment shall be performed by a LPHA or AOD counselor within the first twenty-four (24) hours of admission.
2. If the evidence-based assessment indicates that MAT would be beneficial for the client, within forty-eight (48) hours of the admission:
a. The client must be evaluated by an a LPHA who can determine if MAT initiation is appropriate and prescribe the medication(s).
b. The prescribed MAT medications must be provided to the client in alignment with the program’s approved policies and procedures.
4. Procedures regarding administration, storage, and disposal of MAT, if applicable (HSC Section 11832.9(c)(4); HSC Section 11834.28(c)(4)). This includes:
a. A separate medication policy if MAT is administered, stored, or disposed of differently than non-MAT medications, or include MAT in the current medication administration, storage, and disposal policies and procedures (if applicable);
b. A separate medication policy for MAT shall address:
1. Medication administration requirements for self-administration and documentation;
2. Storage requirements, including location, accessibility, inventory, handling, and documentation;
3. Medication disposal procedures, including how often, methods of destruction, and documentation.
5. Procedures for training for staff regarding administration, storage, and disposal of MAT, if applicable (HSC Section 11832.9(c)(511832.9(c)(4); HSC Section 11834.28(c)(511834.28(c)(4)). This includes:
a. A separate medication policy if MAT is administered, stored, or disposed of differently than non-MAT medications, or include MAT in the current medication administration, storage, and disposal policies and procedures (if applicable);
b. A separate medication policy for MAT shall address:
1. Medication administration requirements for self-administration and documentation;
2. Storage requirements, including location, accessibility, inventory, handling, and documentation;
3. Medication disposal procedures, including how often, methods of destruction, and documentation.
6. An outline of the training the facility will provide to staff on the facility’s MAT policy. (HSC Section 11832.9(c)(6); HSC Section 11834.28(c)(6)). This includes:
a. Frequency of training (upon hire, quarterly, annual, etc.);
b. Qualifications to conduct training;
c. Staff positions required to receive training;
d. Documentation of training in personnel files.
7. A plan that permits a client to use their preferred MAT medication, if the prescriber or MAT provider and the client determine the medication is clinically beneficial. This includes:
a. Access to the facility shall not be denied because of a client’s use of prescribed medications for the treatment of SUD;
b. Assurance that a client is not required to change their MAT medication in order to receive treatment services;
c. Support for a client who wants to continue to receive their preferred MAT medications;
d. Confirmation that a client will not be compelled to taper, discontinue, decrease dosage, or abstain from medications provided as part of MAT as a condition of entering or remaining in the facility ;
e. Assurance that a client is not denied access to medications as part of MAT for not participating in all services offered by a facility ;
f. Assurance that a client is not denied access to medications as part of MAT for substance use or misuse.
8. Procedures for a client to access NTP medications for opioid use disorder (MOUD), including methadone. This includes:
a. Information regarding methadone, including the evidence base, effectiveness, associated risks and benefits, and key considerations to support informed consent;
Appears in 1 contract
Sources: Service Agreement